Schedule 13G ownership disclosure
NOVELION THERAPEUTICS, INC.
Security class unavailable · CUSIP: 67001K202
Event date: 2019-12-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 18.7300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-005508
- Form type
- SC 13G
- Filer
- EdgePoint Investment Group Inc.
- CIK
- CIK 1481669
- Filed
- Jan 10, 2020
- Reporting period
- Dec 20, 2019
- Description
- Schedule 13G beneficial ownership